These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30465193)

  • 1. An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood.
    Uddin I; Joshi K; Oakes T; Heather JM; Swanton C; ; Chain B
    Methods Mol Biol; 2019; 1884():15-42. PubMed ID: 30465193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of the T cell receptor repertoire.
    Uddin I; Woolston A; Peacock T; Joshi K; Ismail M; Ronel T; Husovsky C; Chain B
    Methods Enzymol; 2019; 629():465-492. PubMed ID: 31727254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intra-Tumoral T Cell Receptor Repertoire: Steps Towards a Useful Clinical Biomarker.
    Nageswaran G; Byrne S; Veeriah S; Chain B
    Methods Mol Biol; 2022; 2574():135-158. PubMed ID: 36087200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and Versatile.
    Oakes T; Heather JM; Best K; Byng-Maddick R; Husovsky C; Ismail M; Joshi K; Maxwell G; Noursadeghi M; Riddell N; Ruehl T; Turner CT; Uddin I; Chain B
    Front Immunol; 2017; 8():1267. PubMed ID: 29075258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR Repertoire Analysis Reveals Mobilization of Novel CD8
    Aoki H; Ueha S; Shichino S; Ogiwara H; Hashimoto SI; Kakimi K; Ito S; Matsushima K
    Front Immunol; 2018; 9():3185. PubMed ID: 30733724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
    Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
    Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of TCR β CDR3 sequencing data for tracking anti-tumor immunity.
    Zhang J; Ji Z; Smith KN
    Methods Enzymol; 2019; 629():443-464. PubMed ID: 31727253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic, Prognostic, and Therapeutic Potential of Adaptive Immune Receptor Repertoire Profiling in Cancer.
    Cowell LG
    Cancer Res; 2020 Feb; 80(4):643-654. PubMed ID: 31888887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
    Han Y; Li H; Guan Y; Huang J
    Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
    Ye B; Smerin D; Gao Q; Kang C; Xiong X
    Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes.
    McDaniel JR; DeKosky BJ; Tanno H; Ellington AD; Georgiou G
    Nat Protoc; 2016 Mar; 11(3):429-42. PubMed ID: 26844430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
    Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
    Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell Carcinoma.
    Qureshi HA; Lee SM
    Curr Treat Options Oncol; 2019 Mar; 20(4):31. PubMed ID: 30874960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.
    Nakanishi K; Kukita Y; Segawa H; Inoue N; Ohue M; Kato K
    Cancer Med; 2016 Sep; 5(9):2513-21. PubMed ID: 27465739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy.
    Han J; Lotze MT
    Methods Mol Biol; 2020; 2055():369-397. PubMed ID: 31502161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
    Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
    Schrama D; Ritter C; Becker JC
    Semin Immunopathol; 2017 Apr; 39(3):255-268. PubMed ID: 28074285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.